Little is known about the response of neuropathic tremor to treatment and why it selectively occurs in some people and not others. Methods This case control study investigates the presence and ...
Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by 2028 Study 1 of Essential3 program for ulixacaltamide ...